Aries Wealth Management
Source: SEC Form 13F · as of Mar 2026Aries Wealth Management holds 19 biotech & pharma companies tracked by BioSniper, totaling $25.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$25.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 25,486 | $6.2M |
| LLYELI LILLY & Co | 4,080 | $3.8M |
| MRKMerck & Co., Inc. | 25,532 | $3.1M |
| ABBVAbbVie Inc. | 12,230 | $2.7M |
| ABTABBOTT LABORATORIES | 18,306 | $1.9M |
| IDXXIDEXX LABORATORIES INC /DE | 3,189 | $1.8M |
| MCKMcKesson Corporation | 1,208 | $1.0M |
| KODKodiak Sciences Inc. | 25,000 | $953K |
| AZNASTRAZENECA PLC | 4,561 | $900K |
| PFEPFIZER INC | 29,837 | $838K |
| AXSMAxsome Therapeutics, Inc. | 4,000 | $676K |
| BMYBRISTOL MYERS SQUIBB CO | 10,803 | $655K |
| AMGNAMGEN INC | 898 | $316K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 605 | $270K |
| CORCencora Inc. | 700 | $220K |
| VSTMVerastem, Inc. | 26,249 | $139K |
| EDITEditas Medicine, Inc. | 12,500 | $31K |
| TCRXTScan Therapeutics, Inc. | 10,000 | $10K |
| CGCCanopy Growth Corp | 10,020 | $9K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.